Showing results (1-10 of 5) with videos related to
Sort By:
Pageof 1
Oncology Nursing Forum|August 24, 2001
Exploring the management of bone metastasis according to the Roy Adaptation ModelT Maxwell, E Givant, M O KowalskiAmerican Journal of Clinical Oncology|November 5, 1997
Phase I study combining tumor necrosis factor with interferon-alpha and interleukin-2E D Eskander, H A Harvey, E Givant, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1990
Phase I study of interleukin-2 and interferon alfa-2a as outpatient therapy for patients with advanced malignancyM Hirsh, A Lipton, H Harvey, et al.Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|February 1, 1993
Interleukin-2 and interferon-alpha-2a outpatient therapy for metastatic renal cell carcinomaA Lipton, H Harvey, E Givant, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 12, 2001
A phase I dose-ranging trial of monthly infusions of zoledronic acid for the treatment of osteolytic bone metastasesJ R Berenson, R A Vescio, L S Rosen, et al.Pageof 1